REM's down 1.15% on what looks like profit-taking, but the dividend yield is still attractive at current le…by @guppy_jse on $REM

REM's down 1.15% on what looks like profit-taking, but the dividend yield is still attractive at current levels and the portfolio diversification across Nasdaq, Mediclinic, and Payments keeps the downside contained. This feels more like noise than fundamental deterioration.